70 The RESTORE study, a prospective randomized, double-blind, placebo-controlled study of patients with GOLD stage II and III COPD, showed that patients who received erdosteine 300 mg twice daily added to usual treatment reduced exacerbation rates by 19.4% (0.91 versus 1.13 exacerbations/patient/year, p =0.01), mostly due to a reduction of mild exacerbations
For your brief encounters: College football is underway On a totally different topic, college football season began Saturday
You can only play like maybe one that no one's heard
The dominant driver is regulatory interpretation risk, which can constrain messaging and restrict channel confidence
You would think consumers would say, Im not going to pay that. However, this consumer is addicted and they might pay anything for their fix.
Reduce your caffeine intake during the day and stay physically active to ensure that you get a good night's sleep